Margin operasi Castle Biosciences Corp (CSTL)

Simbol resmi perusahaan Castle Bio (CSTL)

The EBIT margin presented on GURU.Markets demonstrates the resilience of Castle Biosciences (CSTL) driven by skin and GI diagnostics, with the value of -7.40 characterizing this level. Simultaneously, Castle Biosciences (CSTL) is scaling its R&D pipeline by introducing proprietary rapid panels into gastroenterology. The foundation for growth is provided by top dermatologic oncologists attracted by the academic culture and long-term options, ensuring the high quality of medical services.

Castle Biosciences Inc (CSTL): Rentabilitas kegiatan operasi saka 04.07.2022 nganti 19.11.2026

Rincian metrik komprehensif lan analitis Castle Biosciences (CSTL)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:Castle Biosciences Corp
Barang utama Castle Bio

Investors are assessing the stability of Castle Biosciences (CSTL) through the efficiency of its cost management. The operating margin measures the share of profit from the core business before interest and taxes, reflecting internal profitability. An analysis of operating profitability reveals the ability of AI tests to generate cash flow. Growth in this metric confirms the scalability of genomic analytics. Fundamentally, this signals that innovations are transitioning into a stage of sustainable profitability.